What does CUSIP 004225108 represent in this 13F holders report?

CUSIP 004225108 is the security identifier for ACAD - ACADIA PHARMACEUTICALS INC - Common Stock used to aggregate holder disclosures.

How many institutions held ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in Q4 2013?

154 institutional investors reported ACAD - ACADIA PHARMACEUTICALS INC - Common Stock for Q4 2013. Use the holders table for investor-level position and value details.

ACADIA PHARMACEUTICALS INC - Common Stock (ACAD)

CUSIP: 004225108

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class: Equity / Common Stock
Shares outstanding: 170,504,990
Total 13F shares: 83,400,028
Share change: +14,802
Total reported value: $2,083,182,434
Put/Call ratio: 6.6%
Price per share: $24.99
Number of holders: 154
Value change: +$449,614
Number of buys: 1
Number of sells: 3

Quarterly Holders Quick Answers

What is CUSIP 004225108?
CUSIP 004225108 identifies ACAD - ACADIA PHARMACEUTICALS INC - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2014
Previous quarter: Q3 2013

Recent filing periods for CUSIP 004225108:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ACAD - ACADIA PHARMACEUTICALS INC - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
CORRADO ADVISORS, LLC	13F	Company	0.03%	58,335	$1,602,000	—	30 Sep 2013	13F
CITADEL ADVISORS LLC	13F	Company	0.01%	23,686	$651,000	—	30 Sep 2013	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	22,776	$626,000	—	30 Sep 2013	13F
EMORY UNIVERSITY	13F	Company	0%	1,381	$38,000	—	30 Sep 2013	13F

Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) as of Q4 2013

As of 31 Dec 2013, ACADIA PHARMACEUTICALS INC - Common Stock (ACAD) was held by 154 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 83,400,028 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, WESTFIELD CAPITAL MANAGEMENT CO LP, BlackRock Fund Advisors, VIKING GLOBAL INVESTORS LP, PRICE T ROWE ASSOCIATES INC /MD/, GILDER GAGNON HOWE & CO LLC, BlackRock Institutional Trust Company, N.A., and State Street Corp. This page lists 154 institutional shareholders reporting positions in this security for the Q4 2013 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2013 vs Q3 2013 Across Filers

Q3 2013 holders

Q4 2013 holders

154

Holder diff

150

Investor	Q3 2013 Shares	Q4 2013 Shares	Share Diff	Share Chg %	Q3 2013 Value $	Q4 2013 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.